Domestic, foreign drug makers moving to join hands over low-priced drug incentive plan

Korean drug makers and multinationals will be likely to join hands to cope with the government's plan to pass a bill aiming at introducing the controversial incentive system for medical institution's low-priced drug purchase in the National Assembly, although they have sparred over patent infringement and financial contributions method towards scientific events by third party.

The incentive ...